Literature DB >> 7078428

Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat.

H Wurm, E Beubler, E Polz, A Holasek, G Kostner.   

Abstract

Seven rats were infused with 14C-labeled Intralipid at a constant rate of 0.38 ml per hour over a time period of 4 hours. Four rats served as controls and received an infusion of 0.15 M NaCl or of serum albumin two hours after the start of the experiment. In these animals the plasma triglyceride concentration rose linearly from 30 to 240 min and paralleled the total blood radioactivity. The triglyceride concentrations at the end of the experiments were about 25 times as high as at the beginning. Three rats receiving 2 hr after the start an additional infusion of beta 2-glycoprotein-I at a rate of 10 mg per hr showed a markedly enhanced triglyceride removal from the plasma, reaching a steady state which lasted for more than 30 min. It is concluded that beta 2-glycoprotein-I affects the triglyceride clearance under these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7078428     DOI: 10.1016/0026-0495(82)90238-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I).

Authors:  M I Kamboh; R E Ferrell; B Sepehrnia
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

Review 2.  Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS).

Authors:  Alessandra Banzato; Vittorio Pengo
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

3.  Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserine-exposing blood platelets.

Authors:  Edouard M Bevers; Marie P Janssen; Paul Comfurius; Krishnakumar Balasubramanian; Alan J Schroit; Robert F A Zwaal; George M Willems
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

4.  Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (beta 2-glycoprotein I) to anionic phospholipids.

Authors:  M I Kamboh; D R Wagenknecht; J A McIntyre
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

5.  Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; C H Bunker; M Nwankwo; P P Majumder; R E Ferrell
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

6.  Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.

Authors:  J E Hunt; R J Simpson; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.

Authors:  Tong Shi; G Michael Iverson; Jian C Qi; Keith A Cockerill; Matthew D Linnik; Pamela Konecny; Steven A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

8.  Molecular bases of copper and iron deficiency-associated dyslipidemia: a microarray analysis of the rat intestinal transcriptome.

Authors:  Alessandra Tosco; Bianca Fontanella; Rosa Danise; Luigi Cicatiello; Olì M V Grober; Maria Ravo; Alessandro Weisz; Liberato Marzullo
Journal:  Genes Nutr       Date:  2009-10-11       Impact factor: 5.523

9.  Sources of proteins in human bile.

Authors:  B M Mullock; L J Shaw; B Fitzharris; J Peppard; M J Hamilton; M T Simpson; T M Hunt; R H Hinton
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

10.  The insertion of human apolipoprotein H into phospholipid membranes: a monolayer study.

Authors:  S X Wang; G P Cai; S F Sui
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.